Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
NCT Number: NCT03160664
This trial attempts to evaluate the treatment efficacy of magnetic seizure therapy (MST) and its safety for bipolar mania. Half of the participants will receive MST, while the other half will receive electroconvulsive therapy (ECT).
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200030, China
Magnetic seizure therapy (MST) is likely to be an alternative options to electroconvulsive therapy (ECT).
Widespread stimulation of cortical and subcortical regions is inevitable for ECT since the substantial impedance of the scalp and skull shuts most of the electrical stimulus away from the brain. Nevertheless, magnetic pulses are capable to focus the stimulus to a specific area of the brain because they can pass the scalp and skull without resistance. In Addition, electric current will penetrate into deeper structures, while magnetic stimulus are only capable to reach a depth of a few centimeters. As a consequence, MST are able to generate focus stimuli on superficial regions of the cortex while ECT can't, which may give MST the capability to produce comparable therapeutic benefits with the absence of apparent cognitive side effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In addition to treatment as usual (TAU), participants were supposed to receive ten sessions of MST in four weeks, with three sessions per week in the first two weeks and two sessions per week in the following two weeks.
Other names: magnetic seizure therapy
In addition to treatment as usual (TAU), participants were supposed to receive ten sessions of modified ECT in four weeks, with three sessions per week in the first two weeks and two sessions per week in the following two weeks
Other names: electroconvulsive therapy
Participants will engage in their inpatient treatment program as-usual.
Time frame: At baseline, 4-week follow-up
Time frame: At baseline and 4-week follow-up
Time frame: At baseline and 4-week follow-up
Time frame: At baseline and 4-week follow-up
Time frame: At baseline and 24 hours after the first treatment
using single-pulse Transcranial Magnetic Stimulation (sTMS)
Time frame: At baseline, 24 hours after the first treatment, and at 4-week follow-up
measured by Magnetic Resonance Spectroscopy (MRS)
Time frame: At baseline, 24 hours after the first treatment, and at 4-week follow-up
measured by Magnetic Resonance Imaging (MRI)
Time frame: At baseline and 24 hours after the first treatment
measured by electroencephalogram (EEG)
Time frame: At baseline and 24 hours after the first treatment
measured by electroencephalogram (EEG)
Shanghai Mental Health Center
Other
Research on Optimization Program of Magnetic Seizure Therapy for Bipolar Mania Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06462586
Bipolar Disorder, Bipolar Disorder, Manic
Rogers, Arkansas, United States
View Trial DetailsNCT06462612
Bipolar Disorder, Bipolar Disorder, Manic
Bentonville, Arkansas, United States
View Trial DetailsNCT04420793
Bipolar Depression, Bipolar Disorder
Charleston, South Carolina, United States
View Trial DetailsNCT03013400
Bipolar Disorder, Bipolar Disorder, Manic
Oxford, Oxfordshire, United Kingdom
View Trial Details